Related Experiment Video
Updated: Jul 8, 2026
MAME Models for 4D Live-cell Imaging of Tumor: Microenvironment Interactions that Impact Malignant Progression
Published on: February 17, 2012
Understanding the Interplay of CAR-NK Cells and Triple-Negative Breast Cancer: Insights from Computational Modeling
Abazar Arabameri1, Samaneh Arab2
1Department of Electrical Engineering, University of Zanjan, Zanjan, Iran. arabameri@znu.ac.ir.
Abstract:
Chimeric antigen receptor (CAR)-engineered natural killer (NK) cells have recently emerged as a promising and safe alternative to CAR-T cells for targeting solid tumors. In the case of triple-negative breast cancer (TNBC), traditional cancer treatments and common immunotherapies have shown limited effectiveness. However, CAR-NK cells have been successfully employed to target epidermal growth factor receptor (EGFR) on TNBC cells, thereby enhancing the efficacy of immunotherapy. The effectiveness of CAR-NK-based immunotherapy is influenced by various factors, including the vaccination dose, vaccination pattern, and tumor immunosuppressive factors in the microenvironment. To gain insights into the dynamics and effects of CAR-NK-based immunotherapy, we propose a computational model based on experimental data and immunological theories. This model integrates an individual-based model that describes the interplay between the tumor and the immune system, along with an ordinary differential equation model that captures the variation of inflammatory cytokines. Computational results obtained from the proposed model shed light on the conditions necessary for initiating an effective anti-tumor response. Furthermore, global sensitivity analysis highlights the issue of low persistence of CAR-NK cells in vivo, which poses a significant challenge for the successful clinical application of these cells. Leveraging the model, we identify the optimal vaccination time, vaccination dose, and time interval between injections for maximizing therapeutic outcomes.
Insights
Chimeric antigen receptor (CAR)-NK cells show promise for triple-negative breast cancer (TNBC). A computational model reveals optimal dosing and timing strategies to overcome challenges like low CAR-NK cell persistence for effective immunotherapy.
Area of Science:
- Immunology
- Computational Biology
- Oncology
Background:
- Triple-negative breast cancer (TNBC) exhibits limited response to conventional therapies and immunotherapies.
- Chimeric antigen receptor (CAR)-natural killer (NK) cells offer a safer alternative to CAR-T cells for solid tumor treatment.
- CAR-NK cells targeting epidermal growth factor receptor (EGFR) show potential for TNBC immunotherapy.
Purpose of the Study:
- To develop a computational model simulating CAR-NK cell immunotherapy dynamics for TNBC.
- To identify key factors influencing CAR-NK immunotherapy efficacy, including vaccination parameters and tumor microenvironment.
- To determine optimal vaccination strategies for maximizing therapeutic outcomes in TNBC.
Main Methods:
- Integration of an individual-based model (IBM) for tumor-immune system interactions.
- Incorporation of an ordinary differential equation (ODE) model for inflammatory cytokine dynamics.
- Application of computational modeling and global sensitivity analysis to experimental data and immunological theories.
Main Results:
- The model elucidates conditions required for initiating effective anti-tumor responses against TNBC.
- Low in vivo persistence of CAR-NK cells is identified as a critical challenge for clinical application.
- Optimal vaccination time, dose, and injection intervals were computationally determined.
Conclusions:
- CAR-NK cell immunotherapy presents a viable strategy for TNBC treatment.
- Computational modeling is crucial for understanding and optimizing CAR-NK immunotherapy parameters.
- Addressing CAR-NK cell persistence is essential for successful clinical translation in TNBC treatment.
